|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
|
|
|
|
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
Financial Statements
Balance sheet (unaudited)
| Spreadsheets |
Balance sheet (unaudited) | |||
% change from | |||
CHF million | 31.3.06 | 31.12.05 | 31.12.05 |
Assets | |||
Cash and balances with central banks | 5,661 | 5,359 | 6 |
Due from banks | 38,695 | 33,644 | 15 |
Cash collateral on securities borrowed | 356,578 | 300,331 | 19 |
Reverse repurchase agreements | 460,657 | 404,432 | 14 |
Trading portfolio assets | 522,575 | 499,297 | 5 |
Trading portfolio assets pledged as collateral | 169,110 | 154,759 | 9 |
Positive replacement values | 297,740 | 333,782 | (11) |
Financial assets designated at fair value | 895 | 1,153 | (22) |
Loans | 268,026 | 269,969 | (1) |
Financial investments | 6,681 | 6,551 | 2 |
Accrued income and prepaid expenses | 10,671 | 8,918 | 20 |
Investments in associates | 1,569 | 2,956 | (47) |
Property and equipment | 6,916 | 9,423 | (27) |
Goodwill and other intangible assets | 12,420 | 13,486 | (8) |
Other assets | 15,024 | 16,190 | (7) |
Total assets | 2,173,218 | 2,060,250 | 5 |
Liabilities | |||
Due to banks | 137,134 | 124,328 | 10 |
Cash collateral on securities lent | 83,545 | 77,267 | 8 |
Repurchase agreements | 555,995 | 478,508 | 16 |
Trading portfolio liabilities | 205,223 | 188,631 | 9 |
Negative replacement values | 295,917 | 337,663 | (12) |
Financial liabilities designated at fair value | 129,581 | 117,401 | 10 |
Due to customers | 468,607 | 451,533 | 4 |
Accrued expenses and deferred income | 15,129 | 18,392 | (18) |
Debt issued | 173,557 | 160,710 | 8 |
Other liabilities | 55,109 | 53,874 | 2 |
Total liabilities | 2,119,797 | 2,008,307 | 6 |
Equity | |||
Share capital | 871 | 871 | 0 |
Share premium | 9,158 | 9,992 | (8) |
Net gains / (losses) not recognized in the income statement, net of tax | 279 | (182) | |
Revaluation reserve from step acquisitions, net of tax | 38 | 101 | (62) |
Retained earnings | 47,918 | 44,414 | 8 |
Equity classified as obligation to purchase own shares | (119) | (133) | 11 |
Treasury shares | (10,295) | (10,739) | 4 |
Equity attributable to UBS shareholders | 47,850 | 44,324 | 8 |
Equity attributable to minority interests | 5,571 | 7,619 | (27) |
Total equity | 53,421 | 51,943 | 3 |
Total liabilities and equity | 2,173,218 | 2,060,250 | 5 |
TopTerms of Use | Privacy Statement
Products and services in these webpages may not be available for residents of certain nations. Please consult the sales restrictions relating to the service in question for further information.
© UBS 1998-2009. All rights reserved.
